Role of Hyperglycemia in Isogeneic Islet Transplantation: An Experimental Animal Study

Abstract

Objective: Study the role of hyperglycemia-induced β cell loss on grafted islet destruction.

Design: Male inbred rats were made diabetic by streptozotocin administration and used as islet donors and/or isograft recipients to probe directly the role of hyperglycemia as an important determinant of transplanted islet fate, following exclusion of immune-related causes of islet graft destruction like allograft immunity and disease recurrence.

Results: Our studies showed that: a) Hyperglycemia destroyed islet but not pituitary isografts and b) Tight control of normoglycemia by sufficient islet mass engraftment prevented graft damage.

Conclusion: While sustained hyperglycemia caused destruction of transplanted islet isografts, induction of normoglycemia by transplantation of sufficient islet mass to diabetic recipients had a beneficial long term effect on their functional engraftment.

Key words

glucose metabolism - pancreas - insulin - islet transplantation

References

• 1 Ar’ Rajab Ahren B. Prevention of hyperglycemia improves the long term results of islet transplantation in streptozotocin – diabetic rats.  Pancreas. 1992;  7 435-442
• 2 Babcock SK, Gill RG, Bellgrau D, Lafferty KJ. Studies on the two signal model for T cell activation in vivo.  Transpl Proc. 1987;  19 ((1)) 303-306
• 3 Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia.  Diabetes. 2002;  51 66-72
• 4 Emamaullee JA, Stanton L, Schur C, Shapiro AM. Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation.  Diabetes. 2007;  56 1289-1298
• 5 Ferrer-Garcia JC, Merino-Torres JF, Perez Bermejo G, Herrera-Vela C, Ponce-Marco JL, Pinon-Selles F. Insulin induced normoglycemia reduces islet number needed to achieve normoglycemia after allogeneic islet transplantation in diabetic mice.  Cell Transplant.. 2003;  12 849-857
• 6 Gray DWR, Cranston D, MacShane P, Sutton R, Morris PJ. Preferential effect of hyperglycemia on pancreatic islets transplanted into rats beneath the kidney capsule.  Diabetologia. 1989;  32 663-667
• 7 Inoguchi T, Battan R, Handler E, Sportsman JR, Heath M, King GL. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet transplantation.  Proc Natl Acad Sci. 1992;  89 1059-1063
• 8 Lafferty KJ, Gill RL, Babcock SK, Simeonovic CJ. Activation and expression of allograft immunity. In: Progress in Transplantation. 1986: 55-84
• 9 Lafferty KJ, Prowse SJ, Simeonovic CJ. Immunobiology of tissue transplantation: a return to the passenger leucocyte concept.  Annu Rev Immunol. 1983;  1 143-173
• 10 Merino JF, Nacher V, Raurell M, Biarnes M, Soler J, Montanya E. Optimal insulin treatment in syngeneic islet transplantation.  Cell Transplant. 2000;  9 11-18
• 11 Meyer C. Islet transplantation.  N Engl J Med. 2007 Mar 1;  356 ((9)) 963 , ; author reply 964–965
• 12 Morsiani E, Fogli L, Lanza Jr G, Lebow LT, Demetriou AA, Rozga J. Long-term insulin independence following repeated islet transplantation in totally pancreatectomized diabetic pigs.  Cell Transplant. 2002;  11 55-66
• 13 Nomikos IN, Malizos C, Vamvakopoulos NC. Protective and damaging effects of healing.  Wounds. 2006;  18 177-185
• 14 Nomikos IN, Prowse SJ, Carotenuto P, lafferty KJ. Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction.  Diabetes. 1986;  35 1302-1304
• 15 O’Connell PJ, Hawthorne WJ, Holmes-Walker DJ, Nankivell BJ, Gunton JE, Patel AT, Walters SN, Pleass HC, Allen RD, Chapman JR. Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial.  Med J Aust. 2006;  184 ((5)) 221-225
• 16 Prowse SJ, Bellgraau D, Lafferty KJ. Islet allografts are destroyed by disease recurrence in spontaneous diabetic BB rat.  Diabetes. 1986;  35 110-114
• 17 Rajotte RV, Warnock GL, Kneteman NM. Cryopreservation of insulin-producing tissue in rats and dogs.  World J Surg. 1984;  8 179-186
• 18 Ryan EA, Shandro T, Green K, Paty BW, Senior PA, Bigam D, Shapiro AM, Vantyghem MC. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation.  Diabetes. 2004;  (4) 955-962
• 19 Sioutopoulou D, Plakokefalos E, Anifandis G, Arvanitis L, Venizelos I, Valery R, Destouni H, Vamvakopoulos NC. Comparing normal primary endocervical adenoepithelial cells to uninfected and influenza B virus infected human cervical adenocarcinoma HeLa cells.  Int J Gynecol Cancer. 2006;  16 2032-2038
• 20 Stafani MR, Dunlap JA, Yorek MA. Effect of L-fucose on proliferation and myo-inositol metabolismin cultured cerebral microvessel and aortic endothelial cells.  J Cell Physiol. 1992;  153 321-331
• 21 Unger RH, Grundy S. Hyperglycemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes.  Diabetologia. 1985;  28 118-121
• 22 Vakalis NC, Spanacos G, Patsoula Å, Vamvakopoulos NC. Improved detection of Dirofilaria repens DÍÁ by direct polymerase chain reaction.  Parasitology International. 1999;  48 145-150

Correspondence